CSL Limited
ASX:CSL.AX
Sector
Industries
Location
Market Cap
USD 68.07 B
Share Price
USD 140.57
Avg Daily Volume
941,146
Change (1 day)
-3.12%
Change (1 year)
-31.94%
Change (YTD)
-19.34%
CSL Limited Net Income for the year ending June 30, 2024: USD 2.64 B
CSL Limited Net Income is USD 2.64 B for the year ending June 30, 2024, a -20.81% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
-
CSL Limited Net Income for the year ending June 30, 2023 was USD 3.34 B, a 7.30% change year over year.
-
CSL Limited Net Income for the year ending June 30, 2022 was USD 3.11 B, a 30.07% change year over year.
-
CSL Limited Net Income for the year ending June 30, 2021 was USD 2.39 B, a 10.00% change year over year.
-
CSL Limited Net Income for the year ending June 30, 2020 was USD 2.17 B, a 15.87% change year over year.
StockViz
Competitors
Eli Lilly and Company
USD 711.68
LLY
+1.86
0.26%
AbbVie Inc.
USD 210.60
ABBV
+1.10
0.53%
Roche Holding AG
USD 340.96
RO.SW
+1.66
0.49%
Novartis AG
USD 127.06
NOVN.SW
-0.12
-0.10%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 132.59
ABT
+0.59
0.45%
Merck & Co., Inc.
USD 87.37
MRK
+1.29
1.50%
Amgen Inc.
USD 293.72
AMGN
-2.04
-0.69%
Pfizer Inc.
USD 25.88
PFE
+0.14
0.54%
Sanofi
USD 102.38
SAN.PA
+0.86
0.84%
GSK plc
USD 18.80
GSK.L
-0.55
-2.85%
Zoetis Inc.
USD 156.62
ZTS
+1.01
0.65%
Regeneron Pharmaceuticals, Inc.
USD 589.48
REGN
-8.68
-1.45%
Jiangsu Hengrui Medicine Co., Ltd.
USD 9.07
600276.SS
+0.16
1.77%
Becton, Dickinson and Company
USD 199.66
BDX
+3.03
1.54%
Key Data
| Date | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) | Selling, General, and Administrative Expenses (SG&A) |
|---|
Competitors
Eli Lilly and Company
USD 711.68
LLY
+1.86
0.26%
AbbVie Inc.
USD 210.60
ABBV
+1.10
0.53%
Roche Holding AG
USD 340.96
RO.SW
+1.66
0.49%
Novartis AG
USD 127.06
NOVN.SW
-0.12
-0.10%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 132.59
ABT
+0.59
0.45%
Merck & Co., Inc.
USD 87.37
MRK
+1.29
1.50%
Amgen Inc.
USD 293.72
AMGN
-2.04
-0.69%
Pfizer Inc.
USD 25.88
PFE
+0.14
0.54%
Sanofi
USD 102.38
SAN.PA
+0.86
0.84%
GSK plc
USD 18.80
GSK.L
-0.55
-2.85%
Zoetis Inc.
USD 156.62
ZTS
+1.01
0.65%
Regeneron Pharmaceuticals, Inc.
USD 589.48
REGN
-8.68
-1.45%
Jiangsu Hengrui Medicine Co., Ltd.
USD 9.07
600276.SS
+0.16
1.77%
Becton, Dickinson and Company
USD 199.66
BDX
+3.03
1.54%